These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12909491)

  • 1. Gonadotropin-releasing hormone agonist treatment reduced serum interleukin-6 concentrations in patients with ovarian endometriomas.
    Iwabe T; Harada T; Sakamoto Y; Iba Y; Horie S; Mitsunari M; Terakawa N
    Fertil Steril; 2003 Aug; 80(2):300-4. PubMed ID: 12909491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of GnRH agonist treatment on recurrence of ovarian endometriomas after conservative laparoscopic surgery.
    Jee BC; Lee JY; Suh CS; Kim SH; Choi YM; Moon SY
    Fertil Steril; 2009 Jan; 91(1):40-5. PubMed ID: 18377899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secretory leukocyte protease inhibitor in ovarian endometriomas following GnRH agonist therapy.
    Suzumori N; Sato M; Ikuta K; Suzumori K
    Obstet Gynecol; 2001 Apr; 97(4):561-6. PubMed ID: 11275028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.
    Hemmings R
    J Reprod Med; 1998 Mar; 43(3 Suppl):316-20. PubMed ID: 9564667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-8 levels are elevated in patients with ovarian endometrioma.
    Ohata Y; Harada T; Miyakoda H; Taniguchi F; Iwabe T; Terakawa N
    Fertil Steril; 2008 Oct; 90(4):994-9. PubMed ID: 18635170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year follow-up of serum antimüllerian hormone levels in patients with cystectomy: are different sequential changes due to different mechanisms causing damage to the ovarian reserve?
    Sugita A; Iwase A; Goto M; Nakahara T; Nakamura T; Kondo M; Osuka S; Mori M; Saito A; Kikkawa F
    Fertil Steril; 2013 Aug; 100(2):516-22.e3. PubMed ID: 23579006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells.
    Taniguchi F; Higaki H; Azuma Y; Deura I; Iwabe T; Harada T; Terakawa N
    Gynecol Obstet Invest; 2013; 75(1):9-15. PubMed ID: 23147672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopic management of ovarian endometriomas: a critical review of current practice.
    Jones KD; Sutton CJ
    Curr Opin Obstet Gynecol; 2000 Aug; 12(4):309-15. PubMed ID: 10954152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical excision of ovarian endometriomas: Does it truly impair ovarian reserve? Long term anti-Müllerian hormone (AMH) changes after surgery.
    Vignali M; Mabrouk M; Ciocca E; Alabiso G; Barbasetti di Prun A; Gentilini D; Busacca M
    J Obstet Gynaecol Res; 2015 Nov; 41(11):1773-8. PubMed ID: 26420658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic Surgery Combined with GnRH Agonist in Endometriosis.
    Yang Y; Zhu W; Chen S; Zhang G; Chen M; Zhuang Y
    J Coll Physicians Surg Pak; 2019 Apr; 29(4):313-316. PubMed ID: 30925951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of perioperative use of GnRH agonist or dienogest on ovarian reserve after cystectomy for endometriomas: a randomized controlled trial.
    Muraoka A; Osuka S; Yabuki A; Bayasula ; Yoshihara M; Tanaka H; Sonehara R; Miyake N; Murakami M; Yoshita S; Nakanishi N; Nakamura T; Goto M; Iwase A; Kajiyama H
    Reprod Biol Endocrinol; 2021 Dec; 19(1):179. PubMed ID: 34872568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized study comparing the side effects and hormonal status of triptorelin and leuprorelin following conservative laparoscopic surgery for ovarian endometriosis in Chinese women.
    Li Z; Zhang HY; Zhu YJ; Hu YJ; Qu PP
    Eur J Obstet Gynecol Reprod Biol; 2014 Dec; 183():164-8. PubMed ID: 25461372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of preoperative hormonal therapy before laparoscopic cystectomy of ovarian endometriomas.
    Tsujioka H; Inoue Y; Emoto M; Sadamori R; Shirota K; Hachisuga T; Kawarabayashi T
    J Obstet Gynaecol Res; 2009 Aug; 35(4):782-6. PubMed ID: 19751342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in the size of ovarian endometriomas during ovarian suppression in stage IV endometriosis. Role of preoperative medical treatment.
    Rana N; Thomas S; Rotman C; Dmowski WP
    J Reprod Med; 1996 Jun; 41(6):384-92. PubMed ID: 8799912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of effect of preoperative dienogest and gonadotropin-releasing hormone agonist administration on laparoscopic cystectomy for ovarian endometriomas.
    Ozaki R; Kumakiri J; Jinushi M; Ikuma S; Murakami K; Kawasaki Y; Kitade M
    Arch Gynecol Obstet; 2020 Oct; 302(4):969-976. PubMed ID: 32661756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of factors predicting diminished ovarian reserve before and after laparoscopic cystectomy for ovarian endometriomas: a prospective cohort study.
    Ozaki R; Kumakiri J; Tinelli A; Grimbizis GF; Kitade M; Takeda S
    J Ovarian Res; 2016 Jun; 9(1):37. PubMed ID: 27329142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Large ovarian endometriomas.
    Donnez J; Nisolle M; Gillet N; Smets M; Bassil S; Casanas-Roux F
    Hum Reprod; 1996 Mar; 11(3):641-6. PubMed ID: 8671283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Short-term outcome of leuprorelin acetate in preventing recurrence of ovarian endometrioma after conservative surgery].
    Yuan L; Wu QJ; Liu XS
    Zhonghua Fu Chan Ke Za Zhi; 2013 Jul; 48(7):508-10. PubMed ID: 24284221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of gonadotropin-releasing hormone agonist used before surgery on natural pregnancy rates in patients with ovarian endometriomas].
    Chen X; Liu HY; Lang JH; Fan QB; Shi HH; Sun DW; Leng JH; Zhu L; Liu ZF
    Zhonghua Fu Chan Ke Za Zhi; 2018 Oct; 53(10):683-688. PubMed ID: 30369124
    [No Abstract]   [Full Text] [Related]  

  • 20. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
    Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
    Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.